OpenEye, Cadence Molecular Sciences
Anderson Misobuchi has worked as a Scientific Software Developer at OpenEye, Cadence Molecular Sciences since June 2022. Before that, they had experience at The University of Texas at Austin where they worked as a Graduate Researcher from August 2016 to May 2022. Additionally, they served as a Teaching Assistant from August 2016 to May 2022 and as an Assistant Instructor from August 2019 to May 2020.
Anderson Misobuchi has a strong educational background in physics. Anderson obtained a Doctor of Philosophy (PhD) degree in Physics from The University of Texas at Austin, where they studied from 2016 to 2022. Prior to that, they pursued a Master of Science (MS) degree in Physics from USP - Universidade de São Paulo, specializing in the field of Physics, from 2014 to 2016. Anderson completed their undergraduate studies at the same institution, USP - Universidade de São Paulo, earning a Bachelor of Science (BS) degree in Physics from 2010 to 2013.
In addition to their formal education, Anderson has also obtained additional certifications in the field of Machine Learning and Deep Learning. Anderson completed a Deep Learning Specialization course from Coursera in January 2022. Furthermore, they acquired a certification in Machine Learning from Coursera in October 2019.
This person is not in the org chart
This person is not in any offices
OpenEye, Cadence Molecular Sciences
1 followers
OpenEye Scientific is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process. Our scientific approach has focused on visualizing and analyzing the shape and electrostatics of molecular 3D structures to inform and guide the advancement of pharmaceuticals and biotechnology. OpenEye recently integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform. Combining unlimited computation and storage with powerful tools for data sharing, visualization and analysis in an open development platform, Orion offers unprecedented capabilities for drug discovery and optimization. Founded in 1997, OpenEye is a privately held company headquartered in Santa Fe, New Mexico, with offices in Boston, Massachusetts; Cologne, Germany; and Tokyo, Japan. For more information, go to http://www.eyesopen.com.
Employees
51-200